SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 199.20+0.1%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jayhawk969 who wrote (23192)7/14/1998 12:56:00 PM
From: Henry Niman   of 32384
 
JD, If your interested in old diabetes artciles that mention LGND, the FT article also came out:
Message 2911909

As predicted, all three diabetes articles mentioned Ligand. As most readers know, such articles (Business Week, NY Times, and Financial Times), which include quotes, involve interviews with officials at Ligand.. I had been told (last year) by a couple of reliable sources that Ligand would be mentioned in upcoming articles, although such publications should not have been a surprise, based upon the fundamental nature of the Targretin discovery, as well as the interest in new treatments for diabetes.

I certainly would not be surprised to see additional articles on LGND's mimics.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext